| pubmed-article:9479373 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9479373 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:9479373 | lifeskim:mentions | umls-concept:C0262950 | lld:lifeskim |
| pubmed-article:9479373 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
| pubmed-article:9479373 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
| pubmed-article:9479373 | lifeskim:mentions | umls-concept:C0332208 | lld:lifeskim |
| pubmed-article:9479373 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:9479373 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:9479373 | pubmed:dateCreated | 1998-3-5 | lld:pubmed |
| pubmed-article:9479373 | pubmed:abstractText | The report deals with the results of organ-saving surgery for subchondral endoprosthesis carried out in 31 patients with primary tumors and pathological fracture of bones caused by metastasis. An original procedure using the anatomo-physiological peculiarities of cartilage permits to preserve the physiological status of the joint. Lysis of tumor cells in subchondral bone is caused by methyl acrylate used as bone cement. Administration of adaptogen-immunomodulators promotes postoperative healing processes and lowers the risk of infection-related complications. | lld:pubmed |
| pubmed-article:9479373 | pubmed:language | rus | lld:pubmed |
| pubmed-article:9479373 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9479373 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9479373 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9479373 | pubmed:issn | 0507-3758 | lld:pubmed |
| pubmed-article:9479373 | pubmed:author | pubmed-author:StoliarovV... | lld:pubmed |
| pubmed-article:9479373 | pubmed:author | pubmed-author:NeverovV AVA | lld:pubmed |
| pubmed-article:9479373 | pubmed:author | pubmed-author:OrlovaR VRV | lld:pubmed |
| pubmed-article:9479373 | pubmed:author | pubmed-author:MoiseenkoV... | lld:pubmed |
| pubmed-article:9479373 | pubmed:author | pubmed-author:GrechkoA TAT | lld:pubmed |
| pubmed-article:9479373 | pubmed:author | pubmed-author:Shul'nikovV... | lld:pubmed |
| pubmed-article:9479373 | pubmed:author | pubmed-author:AntonovA KAK | lld:pubmed |
| pubmed-article:9479373 | pubmed:author | pubmed-author:AntonovIu... | lld:pubmed |
| pubmed-article:9479373 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9479373 | pubmed:volume | 43 | lld:pubmed |
| pubmed-article:9479373 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9479373 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9479373 | pubmed:pagination | 661-5 | lld:pubmed |
| pubmed-article:9479373 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9479373 | pubmed:meshHeading | pubmed-meshheading:9479373-... | lld:pubmed |
| pubmed-article:9479373 | pubmed:meshHeading | pubmed-meshheading:9479373-... | lld:pubmed |
| pubmed-article:9479373 | pubmed:meshHeading | pubmed-meshheading:9479373-... | lld:pubmed |
| pubmed-article:9479373 | pubmed:meshHeading | pubmed-meshheading:9479373-... | lld:pubmed |
| pubmed-article:9479373 | pubmed:meshHeading | pubmed-meshheading:9479373-... | lld:pubmed |
| pubmed-article:9479373 | pubmed:meshHeading | pubmed-meshheading:9479373-... | lld:pubmed |
| pubmed-article:9479373 | pubmed:meshHeading | pubmed-meshheading:9479373-... | lld:pubmed |
| pubmed-article:9479373 | pubmed:meshHeading | pubmed-meshheading:9479373-... | lld:pubmed |
| pubmed-article:9479373 | pubmed:year | 1997 | lld:pubmed |
| pubmed-article:9479373 | pubmed:articleTitle | [Subchondral endoprosthesis in combined treatment of patients with primary and metastatic tumors of long tubular bones]. | lld:pubmed |
| pubmed-article:9479373 | pubmed:affiliation | Medical Academy of Further Training, St.Petersburg. | lld:pubmed |
| pubmed-article:9479373 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9479373 | pubmed:publicationType | English Abstract | lld:pubmed |
